December Newsletter

The Global Surgical Outcomes Collaboration

GlobalSurg 2 Manuscript Accepted by Lancet ID

The main analysis from GlobalSurg 2 has now been accepted for publication by the leading international journal
The Lancet Infectious Diseases.

Full details are currently under embargo by the journal but we will announce the publication details as soon as we can in early 2018.

Please keep an eye on our newsletter, website and twitter feed for updates

You can also find all of the GlobalSurg publications on our publications page and new GoogleScholar page

2017 has been another fantastic year for GlobalSurg
Thank you & congratulations to all our collaborators for the many successes!

2017 GlobalSurg Highlights 

One of the main events of 2017 for GlobalSurg has been the establishment of the NIHR Global Health Unit on Global Surgery. 

Led by consortium partners, The Universities of Birmingham, Edinburgh and Warwick, the unit will act as a virtual home for the GlobalSurg network and provide substantial funding to establish research hubs around the world.

Each hub will contribute to research prioritisation setting, recruit patients into international clinical trials and contribute data to GlobalSurg international cohort studies. The additional funding will also allow GlobalSurg to provide research training and education in order to build local research capacity and infrastructure.

In November 2017, first hub to open at The University of Witwatersrand, South Africa, hosted the 2nd GlobalSurg Prioritisation Workshop in Johannesburg.
Over 70 International surgeons, researchers and policy makers attended the meeting to discuss and plan future research studies in Access to Surgery, Perioperative Care and Cancer.

Save the date: GlobalSurg 3 Launches Early 2018

The next international GlobalSurg cohort study will launch in early 2018 and will have a cancer theme.

GlobalSurg cohort studies are open to all researchers from medical students upwards, at any hospital, anywhere in the world.

Full study details, including the protocol, how to register and data collection variables, will be announced at the beginning of 2018. Please follow our newsletter, website and Twitter feed for more details as they are announced

GlobalSurg Randomised Controlled Trial

FALCON: Pragmatic multicentre FActorial randomised controlled triaL testing measures to reduCe surgical site infection in lOw and middle income couNtries
 
The first ever GlobalSurg international Clinical Trial will shortly begin recruiting patients. This trial will test whether different skin preparations and closure techniques can reduce surgical site infections. The trial will be carried out at specific hospitals in low and middle income countries.

Thank you to everyone for your continued support and collaboration in GlobalSurg.
Wishing you all a Happy and Peaceful holiday and all the best for 2018Please remember to help spread the news of GlobalSurg and help make 2018 an even better year for GlobalSurg